Advertisement
Canada markets close in 2 hours 59 minutes
  • S&P/TSX

    21,820.60
    +112.16 (+0.52%)
     
  • S&P 500

    4,985.32
    -25.80 (-0.51%)
     
  • DOW

    37,959.50
    +184.12 (+0.49%)
     
  • CAD/USD

    0.7277
    +0.0014 (+0.19%)
     
  • CRUDE OIL

    83.29
    +0.56 (+0.68%)
     
  • Bitcoin CAD

    87,976.34
    +641.13 (+0.73%)
     
  • CMC Crypto 200

    1,377.23
    +64.61 (+4.92%)
     
  • GOLD FUTURES

    2,411.30
    +13.30 (+0.55%)
     
  • RUSSELL 2000

    1,940.99
    -1.97 (-0.10%)
     
  • 10-Yr Bond

    4.6170
    -0.0300 (-0.65%)
     
  • NASDAQ

    15,380.98
    -220.52 (-1.41%)
     
  • VOLATILITY

    18.77
    +0.77 (+4.27%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • CAD/EUR

    0.6828
    +0.0007 (+0.10%)
     

Invitae Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags

Invitae (NYSE:NVTA) Third Quarter 2022 Results

Key Financial Results

  • Revenue: US$133.5m (up 17% from 3Q 2021).

  • Net loss: US$301.2m (loss widened by 52% from 3Q 2021).

  • US$1.27 loss per share (further deteriorated from US$0.91 loss in 3Q 2021).

earnings-and-revenue-growth
earnings-and-revenue-growth

All figures shown in the chart above are for the trailing 12 month (TTM) period

Invitae Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 1.6%. Earnings per share (EPS) missed analyst estimates by 50%.

Looking ahead, revenue is forecast to grow 8.7% p.a. on average during the next 3 years, compared to a 7.5% growth forecast for the Healthcare industry in the US.

ADVERTISEMENT

Performance of the American Healthcare industry.

The company's shares are down 15% from a week ago.

Risk Analysis

It is worth noting though that we have found 5 warning signs for Invitae (1 can't be ignored!) that you need to take into consideration.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here